FDA gives nod to Bristol Myer’s colorectal cancer therapy
The US Food and Drug Administration has greenlighted Bristol Myers Squibb’s combination therapy to treat metastatic colorectal cancer in patients with a mutated.
Drugs
Health
Pharma
Drugs
Health
Pharma
Cancer cases set to rise by 77% to 35 million in 2050: WHO global survey
More than 35 million people may have cancer in 2050 — an increase of 77% from 20 million new cases in 2022, according.
Drugs
Health
Pharma
Type 2 diabetics 47% more prone to develop colorectal cancer: Researchers
HQ Team November 15, 2023: Type 2 diabetic patients, especially African Americans and people with low income, are at a 47% increased risk.
Drugs
Health
Pharma
Bristol Myers acquires Mirati Therapeutics for $5.8 billion
HQ Team October 9, 2023: Bristol Myers Squibb, one of the world’s largest pharmaceutical companies, will acquire Mirati Therapeutics for $5.8 billion through.
Drugs
Medical
Pharma
Free AI tools can predict how long a patient can survive colorectal cancer
HQ Team April 17, 2023: Researchers at the Harvard Medical School and Taiwan’s National Change Kung University have invented a new artificial intelligence.